bamlanivimab anti-COVID drug

bamlanivimab anti-COVID drug

A bamlanivimab anti-COVID drug supply is seen at the Thomayer University Hospital in Prague, Czech Republic, on February 26, 2021. (CTK Photo/Ondrej Deml)

  • Product Code
  • ILEA000276652
  • Registered date
  • 2021/2/26 00:00:00
  • Credit
  • CTK / Kyodo News Images
  • Media source
  • CTK
  • Media size
  • 4701 × 3134 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 8.55(MB)*
  • Special instruction
  • SLOVAKIA OUT, CZECH REPUBLIC OUT
    **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Illustration COSUNTE

    Illustration COSUNTE

    SUQIAN, CHINA - AUGUST 12, 2024 - Illustration COSUNTER, an innovative anti-COVID-19 drug, Suqian city, Jiangsu province, China, August 12, 2024.
      Illustration COSUNTE

      Illustration COSUNTE

      SUQIAN, CHINA - AUGUST 12, 2024 - Illustration COSUNTER, an innovative anti-COVID-19 drug, Suqian city, Jiangsu province, China, August 12, 2024.
        Illustration COSUNTE

        Illustration COSUNTE

        SUQIAN, CHINA - AUGUST 12, 2024 - Illustration COSUNTER, an innovative anti-COVID-19 drug, Suqian city, Jiangsu province, China, August 12, 2024.
          Illustration COSUNTE

          Illustration COSUNTE

          SUQIAN, CHINA - AUGUST 12, 2024 - Illustration COSUNTER, an innovative anti-COVID-19 drug, Suqian city, Jiangsu province, China, August 12, 2024.
            Illustration COSUNTE

            Illustration COSUNTE

            SUQIAN, CHINA - AUGUST 12, 2024 - Illustration COSUNTER, an innovative anti-COVID-19 drug, Suqian city, Jiangsu province, China, August 12, 2024.
              Illustration COSUNTE

              Illustration COSUNTE

              SUQIAN, CHINA - AUGUST 12, 2024 - Illustration COSUNTER, an innovative anti-COVID-19 drug, Suqian city, Jiangsu province, China, August 12, 2024.
                COVID-19 Numbers Spiking In Ontario This Summer

                COVID-19 Numbers Spiking In Ontario This Summer

                A positive COVID-19 rapid test is being shown at a doctor's office in Toronto, Ontario, Canada, on July 23, 2024. COVID-19 numbers are spiking across Ontario this summer as the new COVID-19 variant FLiRT is rapidly spreading throughout Canada. LB.1, or D-FLiRT, is the newest COVID subvariant that is fueling a summer surge in COVID-19 cases along with other new highly contagious variants of the virus (Photo by Creative Touch Imaging Ltd./NurPhoto).
                  COVID-19 Numbers Spiking In Ontario This Summer

                  COVID-19 Numbers Spiking In Ontario This Summer

                  An exam table is sitting at a doctor's office in Toronto, Ontario, Canada, on July 23, 2024. COVID-19 numbers are spiking across Ontario this summer as the new COVID-19 variant FLiRT is rapidly spreading throughout Canada. LB.1, or D-FLiRT, is the newest COVID subvariant that is fueling a summer surge in COVID-19 cases along with other new highly contagious variants of the virus (Photo by Creative Touch Imaging Ltd./NurPhoto).
                    COVID-19 Numbers Spiking In Ontario This Summer

                    COVID-19 Numbers Spiking In Ontario This Summer

                    A positive COVID-19 rapid test is being shown at a doctor's office in Toronto, Ontario, Canada, on July 23, 2024. COVID-19 numbers are spiking across Ontario this summer as the new COVID-19 variant FLiRT is rapidly spreading throughout Canada. LB.1, or D-FLiRT, is the newest COVID subvariant that is fueling a summer surge in COVID-19 cases along with other new highly contagious variants of the virus (Photo by Creative Touch Imaging Ltd./NurPhoto).
                      Pharmacies On Strike

                      Pharmacies On Strike

                      Pharmacists are striking by closing their pharmacies to protest against drug shortages, to demand an increase in their fees from Health Insurance, and to oppose the plan to sell drugs online, in Paris, France, on May 30, 2024. (Photo by Vincent Koebel/NurPhoto)